C2C Wealth Management, LLC - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 29 filers reported holding NOVABAY PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
C2C Wealth Management, LLC ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,000
-88.2%
20,000
-71.0%
0.00%
-100.0%
Q2 2022$17,0000.0%69,080
-1.3%
0.00%0.0%
Q1 2022$17,000
-10.5%
70,000
+37.3%
0.00%0.0%
Q4 2021$19,00051,0000.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 46,903$34,0000.01%
TOWNSQUARE CAPITAL LLC 53,672$40,0000.00%
NVWM, LLC 2,997$2,0000.00%
VANGUARD GROUP INC 152,309$111,0000.00%
UBS Group AG 2,000$1,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 25,000$18,0000.00%
Sugarloaf Wealth Management, LLC 2,000$1,0000.00%
OSAIC HOLDINGS, INC. 5,260$4,0000.00%
BANK OF AMERICA CORP /DE/ 3,000$2,0000.00%
WELLS FARGO & COMPANY/MN 7,514$5,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders